Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary...
Chronic Obstructive Pulmonary DiseaseThis is a 16 week exercise training program for people with severe to very severe chronic obstructive pulmonary disease (COPD). The purpose of this study is to find out if performing strength training prior to initiating exercise training on a stationary bicycle is associated with greater gains in functional status than bicycle training alone or concurrent bicycle and strength training together.
Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive...
Pulmonary DiseaseChronic ObstructiveThe primary objective of this study is to determine the optimum once daily dose of BI 1744 CL and tiotropium in free dose combination (delivered by the Respimat inhaler) after four week treatment in patients with COPD.
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide...
Pulmonary DiseaseChronic ObstructiveThe study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva...
Pulmonary DiseaseChronic ObstructiveNon-inferiority of lung function response to Tiotropium inhalation solution compared to Spiriva HandiHaler
Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers
AsthmaLung DiseasesThe purpose of this study is to characterize the relationship of social stress, coping, and self-regulatory health behaviors in the context of asthma disparities among African American and low income populations.
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva...
Pulmonary DiseaseChronic ObstructiveComparison of lung function response between tiotropium inhalation solution and Spiriva HandiHaler.
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients...
Pulmonary DiseaseChronic ObstructiveThe study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.
Actuation Indicator Trial in Patients With COPD
Pulmonary DiseaseChronic ObstructiveThe primary objective of this study is to evaluate the performance, accuracy, and handling of the actuation indicator in patients with COPD. The actuation indicator is integrated into mouthpiece of the ipratropium bromide HFA inhalation aerosol device. As part of Boehringer Ingelheim's program to qualify an actuation indicator for use with the ipratropium bromide HFA inhalation aerosol device, this study is intended to complement the results from the ongoing in-vitro studies.
Effects of Salmeterol on Walking Capacity in Patients With COPD
Chronic Obstructive Pulmonary DiseaseThis study was designed to test the following hypothesis: The acute changes in exercise tolerance during the endurance shuttle walk will be greater with salmeterol compared to placebo in patients with chronic obstructive pulmonary disease.
Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic...
Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to characterize the dose-response profile of peak and trough FEV1 after single dose administrations of carmoterol in patients with COPD.